A California federal judge has upheld a $2.2 million verdict against Novartis Pharmaceutical Corp. This ruling came in a woman’s lawsuit over a jaw injury allegedly caused by the bone drugs Aredia and Zometa. U.S. District Judge S. James Otero ruled that the drugmaker had a duty to warn of the risk of injury. Judge Otero denied Novartis’ motion for judgment as a matter of law as well as the motion for a new trial. Plaintiff Adriann Georges, according to Judge Otero, sufficiently showed that Novartis had a duty to warn her of the jaw injury risk and that her injury was caused both by her use of the drugs and the drugmaker’s failure to warn.
A number of lawsuits have been filed across the country against Novartis over Aredia and Zometa. The suits were once part of multidistrict litigation in Tennessee before being sent to their home courts. In November, a Florida federal judge refused to put aside a $1.3 million judgment. And in 2012, the company was hit in New York with a $10.5 million verdict. The judge in that case subsequently reduced the award.
Ms. Georges is represented in her case by John Girardi, Thomas Girardi and Molly Girardi, who are with the Girardi Keese firm located in Los Angeles, and by John Vecchione, a lawyer in Fairfax, Va. The case is in the U.S. District Court for the Central District of California.
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.